Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study

dc.contributor.author Bousquet, Jean
dc.contributor.author Antó i Boqué, Josep Maria
dc.contributor.author Pfaar, Oliver
dc.date.accessioned 2023-06-28T06:40:10Z
dc.date.available 2023-06-28T06:40:10Z
dc.date.issued 2023
dc.format.mimetype application/pdf
dc.identifier.citation Bousquet J, Sousa-Pinto B, Shamji MH, Anto JM, Klimek L, Canonica GW, et al. Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study. Clin Exp Allergy. 2023 Aug;53(8):854-61. DOI: 10.1111/cea.14318
dc.identifier.doi http://dx.doi.org/10.1111/cea.14318
dc.identifier.issn 0954-7894
dc.identifier.uri http://hdl.handle.net/10230/57382
dc.language.iso eng
dc.publisher Wiley
dc.relation.ispartof Clin Exp Allergy. 2023 Aug;53(8):854-61
dc.rights © 2023 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.title Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study
dc.type info:eu-repo/semantics/article
dc.type.version info:eu-repo/semantics/publishedVersion

Col·leccions